DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Zonisamide is a drug marketed by Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Bionpharma Inc, Cadila, Epic Pharma Llc, Glenmark Generics, Granules, Heritage Pharma, Invagen Pharms, Mylan, Mylan Pharms Inc, Roxane, Sun Pharm Inds (in), Sun Pharm Industries, Unichem, and Upsher Smith Labs. and is included in eighteen NDAs.
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
A generic version of ZONISAMIDE was approved as zonisamide by APOTEX INC on December 22nd, 2005.
Summary for ZONISAMIDE
Recent Clinical Trials for ZONISAMIDE
Identify potential brand extensions & 505(b)(2) entrants
|The University of Akron||Phase 2|
|University of Texas||Phase 2|
|Gateway Biotechnology, Inc.||Phase 2|
Pharmacology for ZONISAMIDE
|Drug Class||Anti-epileptic Agent |
|Mechanism of Action||Carbonic Anhydrase Inhibitors |
|Physiological Effect||Decreased Central Nervous System Disorganized Electrical Activity |